Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) FCF Margin (2024 - 2025)

Historic FCF Margin for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2025 value amounting to 14.59%.

  • Day One Biopharmaceuticals' FCF Margin fell 1265800.0% to 14.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 104.13%, marking a year-over-year decrease of 156200.0%. This contributed to the annual value of 74.8% for FY2024, which is N/A changed from last year.
  • Per Day One Biopharmaceuticals' latest filing, its FCF Margin stood at 14.59% for Q3 2025, which was down 1265800.0% from 68.2% recorded in Q2 2025.
  • Day One Biopharmaceuticals' 5-year FCF Margin high stood at 111.99% for Q3 2024, and its period low was 1271.11% during Q2 2024.